Dentistry · Papilloma

Mucosal and Genital Papillomas

At a Glance

Most mucosal and genital papillomas are benign, but a new, changing, bleeding, or treatment-resistant growth should be assessed. Care depends on its location, appearance, symptoms, HPV-related risk, and immune health and may include removal, prescription treatment, biopsy, or follow-up.

While most skin papillomas appear on the arms, neck, or trunk, they can also develop in more sensitive areas, such as the mouth, throat, or anogenital region. In these locations, the growths are often managed with a focus on both comfort and long-term monitoring, usually by a dentist, oral specialist, ENT clinician, or sexual-health clinician.

Understanding that these growths are common and manageable can help reduce the stress or stigma often associated with these diagnoses.

Oral and Mucosal Papillomas

An oral squamous papilloma is a benign, slow-growing mass that typically appears on the soft palate, tongue, or lips ^[1]^[2]. These lesions are usually solitary (appearing one at a time) and often look like small, cauliflower-like “bumps” that are the same color as the surrounding tissue ^[1].

Symptoms: Most are asymptomatic, though larger growths or those on the uvula (the “dangly” part of the throat) can occasionally cause a choking sensation or difficulty swallowing ^[3]^[2]. Any new mouth or throat lump deserves individualized assessment.
Treatment: The standard of care is often an excisional biopsy, where the growth is removed with a small margin of healthy tissue ^[4]. Removal can be done with a scalpel, laser, or electrocautery ^[4]^[5].
Recurrence: Once removed, these growths are unlikely to return. One large study found a recurrence rate of only about 2% ^[1]. If they do come back, it typically happens within the first 15 to 18 months after removal ^[4]^[5].

Esophageal Papillomas

Occasionally, an endoscopist may find a papilloma in the esophagus (the tube connecting the throat to the stomach) during an endoscopy for an unrelated issue ^[6]. While these are uncommon and usually benign, malignant potential and management are individualized ^[6]^[7]. An endoscopist and pathologist determine whether removal and follow-up are needed based on lesion size, multiplicity, dysplasia, symptoms, and risk factors such as tobacco or alcohol exposure, rather than incidental status automatically making it low risk ^[8].

Anogenital Warts

Anogenital warts (also called condyloma acuminatum) are benign growths caused by the Human Papillomavirus (HPV), most commonly types 6 and 11 ^[9]. While these specific types are not typically linked to cancer, their presence does not rule out simultaneous high-risk HPV or other disease ^[9]. Routine cervical, anal, or other screening should follow anatomy, age, and current guidelines. Condoms reduce but do not eliminate transmission. Note that an HPV diagnosis usually cannot establish when or from whom it was acquired and does not by itself imply infidelity.

Treatment is individualized based on the number and location of the warts, and you should use a confidential sexual-health resource if needed:

Patient-Applied: Creams or solutions like podophyllotoxin, imiquimod, or sinecatechins can be applied at home over several weeks ^[9]^[10]. These require clinician diagnosis and instructions; they are not interchangeable, should not be used on internal vaginal, cervical, urethral, or intra-anal lesions without specialist direction, and have important pregnancy-related precautions (e.g., avoid podophyllotoxin in pregnancy). Do not use over-the-counter wart products on genital tissue.
Clinician-Applied: A doctor can remove the warts in the office using cryotherapy (freezing), electrosurgery (burning), or surgical excision ^[11]^[12]. Unusual, pigmented, firm, ulcerated, bleeding, or treatment-resistant lesions need examination and sometimes biopsy rather than repeated cream.
Efficacy: While treatments are effective at clearing the visible warts, the virus can sometimes persist in the surrounding skin, leading to recurrences ^[13]. Combining office treatments with at-home creams may help reduce the chance of the warts returning ^[14]^[13].

Considerations for Immunocompromised Patients

The immune system plays a critical role in controlling the growth of papillomas. For patients with a weakened immune system—such as those living with HIV or those who have received an organ transplant—management requires extra care ^[15]^[16].

Increased Risk of Dysplasia: In immunocompromised patients, the virus is more likely to cause dysplasia (abnormal cell growth) or progress toward malignancy ^[17]^[18].
Frequent Monitoring: Doctors may recommend more frequent screenings, such as anal cytology (similar to a Pap smear) or high-resolution anoscopy, to catch any changes early ^[19]^[20]. However, these tests are not automatically appropriate for everyone; decisions depend on the type of immune suppression, anatomy, symptoms, local guidelines, and specialist advice.
Biopsy Importance: Because these growths can look benign even when they contain abnormal cells, a biopsy is more frequently used to confirm the diagnosis and rule out precancerous changes ^[18]^[21].

If you are immunocompromised and notice a papilloma growing rapidly or changing, notify your care team immediately for a detailed evaluation ^[22]^[4]. Routine high-risk HPV testing is generally not used to diagnose an oral squamous papilloma; examination and biopsy are the usual tools.

Common questions in this guide

Are oral papillomas cancerous?

Most oral squamous papillomas are benign, slow-growing growths and are often solitary. A new mouth or throat lump still needs individual assessment, and removal with a biopsy may be recommended to confirm the diagnosis.

What treatment is used for a papilloma in the mouth or throat?

The usual treatment is removal with an excisional biopsy, using a scalpel, laser, or electrocautery. The best approach depends on the growth’s location, size, symptoms, and examination findings.

Can genital warts return after treatment?

Yes. Treatment can clear visible warts, but HPV may remain in nearby skin and allow new warts to appear. Your clinician can advise whether follow-up is needed.

Do genital warts mean cancer or infidelity?

Anogenital warts are usually caused by low-risk HPV types 6 and 11, which are not typically linked to cancer. An HPV diagnosis usually cannot show when or from whom it was acquired and does not by itself imply infidelity, although high-risk HPV or another condition can occur at the same time.

How are anogenital warts treated safely?

After a clinician confirms the diagnosis, some external warts can be treated at home with prescribed podophyllotoxin, imiquimod, or sinecatechins. Clinician-applied options include freezing, electrosurgery, or excision; internal lesions and pregnancy require specific medical guidance, and over-the-counter wart removers should not be used on genital tissue.

Why might someone with a weakened immune system need extra monitoring?

A weakened immune system, including from HIV or an organ transplant, can make abnormal cell changes more likely. Clinicians may recommend more frequent screening or biopsy depending on the person’s anatomy, symptoms, type of immune suppression, and local guidance.

Does an esophageal papilloma always need to be removed?

Not necessarily. The endoscopy specialist and pathologist consider the growth’s size, number, symptoms, abnormal cell changes, and risk factors such as tobacco or alcohol exposure when deciding about removal and follow-up; finding it incidentally does not automatically mean it is low risk.

Get notified when new evidence is published on skin papilloma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

Most oral squamous papillomas are solitary, benign growths, but any new mouth or throat lump needs individualized assessment.
Oral papillomas are commonly removed with an excisional biopsy using a scalpel, laser, or electrocautery, and recurrence after removal is uncommon.
Esophageal papillomas are uncommon and usually benign, but removal and follow-up depend on their size, number, symptoms, abnormal cell changes, and risk factors.
Anogenital warts are usually caused by low-risk HPV types 6 and 11; prescription treatments or clinician-applied procedures can clear visible warts, but over-the-counter wart products should not be used on genital tissue.
People with weakened immune systems may need more frequent examination, screening, or biopsy because abnormal cell changes are more likely and lesions can be harder to assess.

References (22)

1
Clinical, histopathological and immunohistochemical study of oral squamous papillomas.
Frigerio M, Martinelli-Kläy CP, Lombardi T
Acta odontologica Scandinavica 2015; (73(7)):508-15 doi:10.3109/00016357.2014.996186.
PMID: 25598510
2
Benign Symptomatic Squamous Papilloma of the Uvula: A Case Report and Review of the Literature.
Albasry EA, Alyousef ZM, Alazizi MA
Cureus 2023; (15(1)):e33602 doi:10.7759/cureus.33602.
PMID: 36636519
3
An Atypical Squamous Papilloma of the Uvula.
Apandi A, Sai Guan L, Mohamad A, et al.
Cureus 2024; (16(4)):e58008 doi:10.7759/cureus.58008.
PMID: 38738073
4
Success Rate of Benign Oral Squamous Papilloma Treatments After Different Surgical Protocols (Conventional, Nd:YAG, CO2 and Diode 980 nm Lasers): A 34-Year Retrospective Study.
Nammour S, Mobadder ME, Namour A, et al.
Photobiomodulation, photomedicine, and laser surgery 2021; (39(2)):123-130 doi:10.1089/photob.2020.4916.
PMID: 33450170
5
Recurrence rate of oral squamous cell papilloma after excision with surgical scalpel or laser therapy: A retrospective cohort study.
Toledano-Serrabona J, López-Ramírez M, Sánchez-Torres A, et al.
Medicina oral, patologia oral y cirugia bucal 2019; (24(4)):e433-e437 doi:10.4317/medoral.22943.
PMID: 31232385
6
Prevalence of esophageal squamous papilloma (ESP) and associated cancer in northeastern France.
d'Huart MC, Chevaux JB, Bressenot AM, et al.
Endoscopy international open 2015; (3(2)):E101-6 doi:10.1055/s-0034-1390976.
PMID: 26135647
7
Esophageal squamous papilloma: Literature review and case-control retrospective study with histopathological exam of human papillomavirus.
Ahmad AI, Lee A, Nithagon P, et al.
JGH open : an open access journal of gastroenterology and hepatology 2023; (7(10)):674-681 doi:10.1002/jgh3.12942.
PMID: 37908288
8
Esophageal Squamous Papilloma and Papillomatosis: Current Evidence of HPV Involvement and Malignant Potential.
Mercurio M, de Sire R, Campagnoli P, et al.
Cancers 2025; (17(14)) doi:10.3390/cancers17142404.
PMID: 40723286
9
Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis.
Jung JM, Jung CJ, Lee WJ, et al.
The British journal of dermatology 2020; (183(1)):24-36 doi:10.1111/bjd.18638.
PMID: 31675442
10
2024 recommendations for the therapeutic management of anogenital warts.
Boyer M, Boyer M, Joly E, et al.
Annales de dermatologie et de venereologie 2026; (153(3)):103510 doi:10.1016/j.annder.2026.103510.
PMID: 42235479
11
Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis.
Barton S, Wakefield V, O'Mahony C, Edwards S
BMJ open 2019; (9(10)):e027765 doi:10.1136/bmjopen-2018-027765.
PMID: 31676644
12
Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials.
Bertolotti A, Ferdynus C, Milpied B, et al.
Dermatology and therapy 2020; (10(2)):249-262 doi:10.1007/s13555-020-00357-z.
PMID: 32030564
13
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial.
Puviani M, Galluzzo M, Talamonti M, et al.
International journal of STD & AIDS 2019; (30(2)):131-136 doi:10.1177/0956462418797874.
PMID: 30236042
14
A systematic review evaluating the efficacy and safety of a combination of ablative treatment and self administered treatment versus ablative treatment alone for external anogenital warts.
Feng C, Li W, Wang X, et al.
International journal of dermatology 2020; (59(10)):1210-1216 doi:10.1111/ijd.14863.
PMID: 32297994
15
Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
Bacik LC, Chung C
International journal of dermatology 2018; (57(6)):627-634 doi:10.1111/ijd.13819.
PMID: 29152727
16
Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review.
Bushara O, Krogh K, Weinberg SE, et al.
Pathobiology : journal of immunopathology, molecular and cellular biology 2022; (89(1)):1-12 doi:10.1159/000518758.
PMID: 34535611
17
Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis.
Jin F, Vajdic CM, Poynten IM, et al.
The Lancet. Oncology 2024; (25(7)):933-944 doi:10.1016/S1470-2045(24)00189-X.
PMID: 38936380
18
High-risk human papilloma virus, precancerous lesions and cancer in anal condylomas.
Albuquerque A, Cappello C, Stirrup O
AIDS (London, England) 2021; (35(12)):1939-1948 doi:10.1097/QAD.0000000000002975.
PMID: 34101627
19
New Insights into the Role of Human Papillomavirus in Anal Cancer and Anal Wart Development.
Albuquerque A, Medeiros R
Acta cytologica 2019; (63(2)):118-123 doi:10.1159/000491815.
PMID: 30861525
20
Prevalence and risk factors of anal human papillomavirus infection among men with anal condyloma acuminata by HIV status in ShenZhen, Southeast China: A retrospective cohort study.
Liu J, Yang R, Huang J, et al.
Journal of medical virology 2023; (95(12)):e29282 doi:10.1002/jmv.29282.
PMID: 38082477
21
Squamous cell anal cancer: Management and therapeutic options.
Pessia B, Romano L, Giuliani A, et al.
Annals of medicine and surgery (2012) 2020; (55()):36-46 doi:10.1016/j.amsu.2020.04.016.
PMID: 32461801
22
Malignant transformation of oral squamous cell papilloma: a case report.
Hassan Saad R, Halawa SM, Zidan AM, et al.
International journal of surgery case reports 2020; (75()):348-351 doi:10.1016/j.ijscr.2020.09.064.
PMID: 32980707

This page is for informational purposes only and does not constitute medical advice. A qualified clinician should evaluate any new oral, throat, esophageal, or anogenital growth, especially if it changes, bleeds, or occurs with immunosuppression.